News

Brad Nutter, chairman of Haemonetics’ board of directors, said, “We appreciate Rich’s leadership and guidance during his four-year tenure with Haemonetics. His breadth of experience in healthcare has

According the news source, the drug maker plans to close the plant in phases over a period of three years. The closure of the plant is expected to

Pursuant to the terms of the acquisition, Varian is retaining the proton therapy business, which will now operate as Varian Particle Therapy, while Bruker has acquired substantially all

The license and collaboration revenue for the fourth quarter of 2008 increased 44% to $2.2 million from $1.5 million for the fourth quarter of 2007. For the year

Net sales for the three months ended February 28, 2009 were $49.45 million, a 21% increase over the $40.72 million reported for the three months ended February 28,

Arkansas Children’s Hospital has installed Toshiba America Medical Systems’s Aquilion ONE 320-detector row CT system to lower radiation dose, which is particularly important when imaging pediatric patients. Toshiba

DeBlasi previously worked for Applera Corporation. He served as the chief accounting officer for a total of eight years during his tenure with Applera. For the last five

Harvest Technologies, a developer of new technologies for accelerating healing, has announced that the interim study report was completed for the first 30 patients in the clinical trial

Karo Bio, a drug discovery and development company, has reported that compound KB3305, a liver selective antagonist for the glucocorticoid receptor, showed clinically relevant and statistically significant effects